Table 2.
Measurement | SCL | CL | CON |
---|---|---|---|
5-HT (ng/ml) | 33.11 ± 17.33 | 21.85 ± 15.12 | 35.11 ± 16.63 |
ET-1 (pg/ml) | 40.96 ± 18.07 | 38.91 ± 12.66 | 52.63 ± 15.04 |
iNOS (ng/ml) | 5.86 ± 1.44 | 7.00* ± 2.69 | 5.90 ± 3.10 |
TXB2 (pg/ml) | 193.05 ± 34.84 | 291.80** ± 50.68 | 189.47 ± 46.40 |
The subclinical group (SCL) and the chronic group (CL) were compared with the healthy group (CON), and there was no comparison between the subclinical group and the chronic group. * indicates that the difference is significant (P < 0.05), and ** indicates that the difference is extremely significant (P < 0.01)